Which of the following statements is correct: a) Hepatitis is a major side effect of ethambutol; b) Arthritis is a side effect of rifampicin; c) Isoniazid can be given at a maximum dose of 600 mg; d) Cerebrospinal fluid in tuberculous meningitis shows lymphocytic pleocytosis, elevated protein (albumin), and low glucose; e) Bacillus Calmette‑Guérin (BCG) vaccination is recommended in countries with low tuberculosis prevalence?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 10, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Correct Answer: Statement D

The correct statement is (d): In cerebrospinal fluid from a patient with tuberculous meningitis, lymphocytic pleocytosis, elevated protein (albumin), and decreased glucose are found. 1, 2, 3

Analysis of Each Statement

Statement A: Hepatitis as Major Side Effect of Ethambutol - INCORRECT

  • Ethambutol's major side effect is optic neuritis/ocular toxicity, not hepatitis 1
  • The hepatotoxic anti-tuberculous drugs are isoniazid, rifampicin, and pyrazinamide 1
  • Ethambutol can be used with caution even in patients with liver disease, as it is not significantly hepatotoxic 1

Statement B: Arthritis as Side Effect of Rifampicin - INCORRECT

  • Arthritis is not a recognized major side effect of rifampicin 1
  • Rifampicin's main side effects include hepatotoxicity, drug interactions (reduces efficacy of oral contraceptives and sulphonylureas), and orange discoloration of body fluids 1
  • Arthritis/arthralgias are actually associated with pyrazinamide, not rifampicin

Statement C: Isoniazid Maximum Dose of 600 mg - INCORRECT

  • The maximum dose of isoniazid is 300 mg daily, not 600 mg 1
  • Recommended dosing is 5 mg/kg up to a maximum of 300 mg/day according to IUATLD and WHO 1
  • Some sources recommend 10 mg/kg up to a maximum of 300 mg daily, but the ceiling remains 300 mg 1

Statement D: CSF Findings in Tuberculous Meningitis - CORRECT

  • Characteristic CSF findings in tuberculous meningitis include lymphocytic pleocytosis, elevated protein, and low glucose 1, 2, 3
  • This is the classic triad described in all major guidelines 1, 3
  • Specifically: lymphocytic-predominant pleiocytosis (>50% lymphocytes), protein >1 g/L, and glucose <2.2 mmol/L 4, 5
  • Early in disease, neutrophils may predominate, but lymphocytes become predominant as disease progresses 4

Statement E: BCG Vaccination in Low Prevalence Countries - INCORRECT

  • BCG vaccination is not recommended in countries with low tuberculosis prevalence
  • BCG is recommended in countries with high tuberculosis prevalence and high transmission rates
  • In low-prevalence settings, BCG vaccination is typically reserved for high-risk individuals only, not given universally

Clinical Pearls for CSF in Tuberculous Meningitis

Key diagnostic features: 3, 4, 5

  • Lymphocytic pleocytosis: Usually 10-500 cells/μL with >50% lymphocytes
  • Elevated protein: Typically >1 g/L (100 mg/dL)
  • Low glucose: <2.2 mmol/L or CSF:serum glucose ratio <0.5
  • CSF ADA >6 U/L has 95% specificity and positive likelihood ratio of 10.7 5

Important caveats: 4

  • Early in disease (first few days), neutrophils may predominate (>50%), which can be misleading
  • Multiple large-volume CSF samples increase diagnostic yield for AFB smear and culture 3
  • Treatment should be initiated based on clinical suspicion and characteristic CSF findings, without waiting for culture confirmation 1, 2, 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

CNS Tuberculosis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Tuberculous meningitis: diagnosis and treatment overview.

Tuberculosis research and treatment, 2011

Research

The validity of cerebrospinal fluid parameters for the diagnosis of tuberculous meningitis.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2013

Related Questions

What is the diagnosis for a patient with meningitis, lymphocytic (lymphocytes) predominance, and hypoglycemia (low glucose), with low cerebrospinal fluid (CSF) glucose and low serum glucose?
What is pleocytosis in tuberculous meningitis?
What is the most appropriate treatment for a patient with signs and symptoms of meningitis, low cerebrospinal fluid (CSF) glucose, elevated CSF protein, and predominant lymphocytes?
What is the most likely diagnosis for a drug user presenting with a 3-week history of fever and headache, worsening over the past 3 days, and cerebrospinal fluid (CSF) analysis showing hypoglycorrhachia (low glucose), elevated protein, and lymphocytic predominance?
Should anti-tubercular therapy (ATT) be considered in a patient with cerebral venous thrombosis (CVT) and venous hemorrhagic infarct, and cerebrospinal fluid (CSF) studies showing elevated protein, low sugar, and lymphocytic predominance, but a normal adenosine deaminase (ADA) level, given a concern for tuberculous meningitis?
What is the immediate management of a patient presenting with diabetic ketoacidosis?
What are the DECA criteria for diagnosing, grading severity, assessing control, and managing allergic conjunctivitis in adults and children?
What are the causes of a positive fecal occult blood test (FOBT)?
What are the best criteria to grade the severity of allergic conjunctivitis?
How should I evaluate and manage an adult patient with low thyroid‑stimulating hormone and mildly elevated free thyroxine?
What is high-output heart failure?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.